Skip to main navigation Skip to search Skip to main content

Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: Update of an ongoing study

  • J. M. Nedzelski
  • , C. M. Chiong
  • , G. Fradet
  • , D. A. Schessel
  • , G. E. Bryce
  • , A. G. Pfleiderer
  • University of Toronto

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Abstract

A prospective study using intratympanic gentamicin instillation as treatment for disabling unilateral Meniere's disease has been ongoing at our institution for 4 years. Treatment effectiveness is evaluated based on the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 1985 guidelines. This report is based on 30 patients who have become eligible for assessment. We conclude that gentamicin intratympanic instillation as currently used in our protocol is an effective, safe, and easily administered method of achieving a predictable measure of vertigo control.

Original languageEnglish
Pages (from-to)278-282
Number of pages5
JournalAmerican Journal of Otology
Volume14
Issue number3
StatePublished - 1993

Fingerprint

Dive into the research topics of 'Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: Update of an ongoing study'. Together they form a unique fingerprint.

Cite this